Letomore 5 Tablet contains Letrozole (5mg), an effective medication primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. Letrozole belongs to the class of aromatase inhibitors, which function by reducing estrogen levels in the body. Estrogen can stimulate the growth of certain types of breast cancer, and by lowering its levels, Letmore 5 helps slow or stop the growth of these cancer cells.
This medication is often prescribed as an adjuvant treatment following surgery, radiation, or chemotherapy, particularly for breast cancer patients who are postmenopausal and have hormone receptor-positive tumors. Letomore 5 is also used for the treatment of advanced-stage breast cancer to reduce recurrence. In certain cases, Letrozole is used to help induce ovulation in women with infertility, particularly those diagnosed with polycystic ovary syndrome (PCOS).
Letmore 5 works by inhibiting the aromatase enzyme, which is responsible for the production of estrogen in postmenopausal women. By blocking estrogen production, Letmore helps reduce the risk of cancer cell growth, and for women with PCOS, it encourages ovulation.
The recommended dosage is generally one tablet per day, and it should be taken as prescribed by the doctor. The dose and duration of the treatment will depend on the patient’s condition and response to therapy. Letomore 5 can be taken with or without food.